What's new in bacterial vaginosis and trichomoniasis?

Infectious Disease Clinics of North America

Volumn 19, Issue 2 SPEC. ISS., 2005, Pages 387-406

  Sobel, Jack D ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROIMIDAZOLE; CLINDAMYCIN; METRONIDAZOLE; TINIDAZOLE;

CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HUMAN; NEUROTOXICITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SIDE EFFECT; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINA CANDIDIASIS; VAGINITIS;

EID: 20444439551     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2005.03.001     Document Type: Review

References (101)

1. H. Schneider, D.J. Coetzee, and H.G. Fehler Screening for sexually transmitted diseases in rural South African women Sex Transm Infect 74 Suppl 1 1998 S147 S152
2. P. Moodley, C. Connolly, and A.W. Sturm Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts J Infect Dis 185 2002 69 73
3. World Health Organization An overview of selected curable sexually transmitted diseases 1995 WHO Global program on AIDS Geneva (Switzerland) p. 2-27
4. A.C. Fouts, and S.J. Kraus Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis J Infect Dis 141 1980 137 143
5. D. Soper Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 190 2004 281 290
6. F.J. Bowden, and G.P. Garnett Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions Sex Transm Infect 76 2000 248 256
7. F. Sorvillo, L. Smith, and P. Kerndt Trichomonas vaginalis, HIV, and African-Americans Emerg Infect Dis 7 2001 927 932
8. S.B. Saxena, and R.R. Jenkins Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases Sex Transm Dis 18 1991 138 142
9. T.E. Weston, and C.S. Nicol Natural history of trichomonal infection in males Br J Vener Dis 39 1963 251 257
10. M.F. Cotch, J.G. Pastorek II, and R.P. Nugent Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group Sex Transm Dis 24 1997 353 360
11. H. Minkoff, A.N. Grunebaum, and R.H. Schwarz Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy Am J Obstet Gynecol 150 1984 965 972
12. M.A. Klebanoff, J.C. Carey, and J.C. Hauth National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection N Engl J Med 345 2001 487 493
13. C.C. Wang, R.S. McClelland, and M. Reilly The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1 J Infect Dis 183 2001 1017 1022
14. F. Sorvillo, and P. Kerndt Trichomonas vaginalis and amplification of HIV-1 transmission Lancet 351 1998 213 214
15. G.A. Dallabetta, P.G. Miotti, and J.D. Chiphangwi High socioeconomic status is a risk factor for human immunodeficiency virus type 1 (HIV-1) infection but not for sexually transmitted diseases in women in Malawi: implications for HIV-1 control J Infect Dis 167 1993 36 42
16. M. Laga, M. Alary, and N. Nzila Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers Lancet 344 1994 246 248
17. D.W. Cameron, and N.S. Padian Sexual transmission of HIV and the epidemiology of other sexually transmitted diseases AIDS 4 Suppl 1 1990 S99 S103
18. S. Cu-Uvin, J.W. Hogan, and D. Warren Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group Clin Infect Dis 29 1999 1145 1150
19. P. Moodley, D. Wilkinson, and C. Connolly Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus Clin Infect Dis 34 2002 519 522
20. F. Grodstein, M.B. Goldman, and L. Ryan Relation of female infertility to consumption of caffeinated beverages Am J Epidemiol 137 1993 1353 1360
21. K.J. Sherman, J.R. Daling, and N.S. Weiss Sexually transmitted diseases and tubal infertility Sex Transm Dis 14 1987 12 16
22. A.M. El-Shazly, H.M. El-Naggar, and M. Soliman A study on Trichomoniasis vaginalis and female infertility J Egypt Soc Parasitol 31 2 2001 545 553
23. R. Paisarntantiwong, S. Brockmann, and L. Clarke The relationship of vaginal trichomoniasis and pelvic inflammatory disease among women colonized with Chlamydia trachomatis Sex Transm Dis 22 1995 344 347
24. D.E. Soper, R.C. Bump, and W.G. Hurt Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy Am J Obstet Gynecol 63 1990 1016 1021
25. Z.F. Zhang, and C.B. Begg Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies Int J Epidemiol 23 1994 682 690
26. M. Viikki, E. Pukkala, and P. Nieminen Gynaecological infections as risk determinants of subsequent cervical neoplasia Acta Oncol 39 2000 71 75
27. E.H. Yap, T.H. Ho, and Y.C. Chan Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients Genitourin Med 71 1995 402 404
28. S.A. Sayed el-Ahl, H.S. el-Wakil, and N.M. Kamel A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women J Egypt Soc Parasitol 32 2002 167 178
29. J.N. Krieger, and J.D. Alderete Trichomoniasis vaginalis and trichomoniasis K.K. Holmes P.F. Sparling P. Mardh Sexually transmitted diseases 3rd edition 1999 McGraw-Hill New York 587 604
30. W.A. Gardner Jr., D.E. Culberson, and B.D. Bennett Trichomonas vaginalis in the prostate gland Arch Pathol Lab Med 110 1986 430 432
31. V. Skerk, S. Schonwald, and I. Krhen Aetiology of chronic prostatitis Int J Antimicrob Agents 19 2002 471 474
32. F. Martinez-Garcia, J. Regadera, and R. Mayer Protozoan infections in the male genital tract J Urol 156 1996 340 349
33. J.C. Jarecki-Black, W.B. Lushbaugh, and L. Golosov Trichomonas vaginalis: preliminary characterization of a sperm motility inhibiting factor Ann Clin Lab Sci 18 1988 484 489
34. K.A. Borchardt, S. al-Haraci, and N. Maida Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test Genitourin Med 71 1995 405 406
35. J.R. Schwebke, and L.F. Lawing Improved detection by DNA amplification of Trichomonas vaginalis in males J Clin Microbiol 40 2002 3681 3683
36. K.A. Wendel, E.J. Erbelding, and C.A. Gaydos Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis Clin Infect Dis 35 2002 576 580
37. J.L. Joyner, J.M. Douglas Jr., and S. Ragsdale Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic Sex Transm Dis 27 2000 236 240
38. Sexually transmitted diseases treatment guidelines 2002 Centers for Disease Control and Prevention MMWR Recomm Rep 51 2002 44 45
39. J.G. Lossick, and H.L. Kent Trichomoniasis: trends in diagnosis and management Am J Obstet Gynecol 165 1991 1217 1222
40. I.H. Ahmed-Jushuf, A.E. Murray, and J. McKeown Managing trichomonal vaginitis refractory to conventional treatment with metronidazole Genitourin Med 64 1988 25 29
41. J.D. Sobel, P. Nyirjesy, and W. Brown Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis Clin Infect Dis 33 2001 1341 1346
42. W.D. Hager Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients Sex Transm Dis 31 2004 343 345
43. A.L. Crowell, K.A. Sanders-Lewis, and W.E. Secor In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis Antimicrob Agents Chemother 47 2003 1407 1409
44. E.M. Narcisi, and W.E. Secor In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis Antimicrob Agents Chemother 40 1996 1121 1125
45. D.A. Eschenbach History and review of bacterial vaginosis Am J Obstet Gynecol 169 1993 441 445
46. R.L. Goldenberg, M.A. Klebanoff, and R. Nugent Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group Am J Obstet Gynecol 174 1996 1618 1621
47. J.M. Riduan, S.L. Hillier, and B. Utomo Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy Am J Obstet Gynecol 169 1993 175 178
48. A. Hallen, C. Pahlson, and U. Forsum Bacterial vaginosis in women attending STD clinic: diagnostic criteria and prevalence of Mobiluncus spp Genitourin Med 63 1987 386 389
49. S. Smart, A. Singal, and A. Mindel Social and sexual risk factors for bacterial vaginosis Sex Transm Infect 80 2004 58 62
50. J.M. Marrazzo, L.A. Koutsky, and D.A. Eschenbach Characterization of vaginal flora and bacterial vaginosis in women who have sex with women J Infect Dis 185 2002 1307 1313
51. S. Yen, M.A. Shafer, and J. Moncada Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military Obstet Gynecol 102 2003 927 933
52. R.B. Ness, S. Hillier, and H.E. Richter Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc 95 2003 201 212
53. P. Thorsen, I.P. Jensen, and B. Jeune Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women Am J Obstet Gynecol 178 1998 580 587
54. D.M. Ward, M.M. Bateson, and R. Weller Ribosomal RNA analysis of microorganisms as they occur in nature K.C. Marshall Advances in microbial ecology vol. 12 1992 Plenum Press New York 219 286
55. M.J. Ferris, A. Masztal, and K.E. Aldridge Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis BMC Infect Dis 4 2004 5
56. H. Verstraelen, R. Verhelst, and G. Claeys Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis Am J Obstet Gynecol 191 2004 1130 1132
57. S. Cauci, R. Monte, and M. Ropele Pore-forming and haemolytic properties of the Gardnerella vaginalis cytolysin Mol Microbiol 9 1993 1143 1155
58. J.J. Platz-Christensen, I. Mattsby-Baltzer, and P. Thomsen Endotoxin and interleukin-1 alpha in the cervical mucus and vaginal fluid of pregnant women with bacterial vaginosis Am J Obstet Gynecol 169 1993 1161 1166
59. S. Cauci, S. Guaschino, and D. De Aloysio Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women Mol Hum Reprod 9 2003 53 58
60. S. Cauci, S. Driussi, and D. De Santo Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women J Clin Microbiol 40 2002 2147 2152
61. S. Cauci Vaginal immunity in bacterial vaginosis Curr Infect Dis Rep 6 2004 450 456
62. S. Cauci, S. Driussi, and S. Guaschino Correlation of local interleukin-1beta levels with specific IgA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis Am J Reprod Immunol 47 2002 257 264
63. M.H. Yudin, D.V. Landers, and L. Meyn Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial Obstet Gynecol 102 2003 527 534
64. M.R. Genc, S.S. Witkin, and M.L. Delaney A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth Am J Obstet Gynecol 190 2004 1191 1197
65. S.L. Hillier, M.A. Krohn, and E. Cassen The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes Clin Infect Dis 20 Suppl 2 1995 S276 S278
66. R.L. Goldenberg, and J.F. Culhane Infection as a cause of preterm birth Clin Perinatol 30 2003 677 700
67. J.A. McGregor, and J.I. French Bacterial vaginosis in pregnancy Obstet Gynecol Surv 55 5 Suppl 1 2000 S1 S19
68. S.L. Hillier, J. Martius, and M. Krohn A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity N Engl J Med 319 1988 972 978
69. E.H. Koumans, L.E. Markowitz, V. Hogan, and CDC BV Working Group Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data Clin Infect Dis 35 Suppl 2 2002 S152 S172
70. L.L. Klein, and R.S. Gibbs Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth Am J Obstet Gynecol 190 2004 1493 1502
71. H. Leitich, M. Brunbauer, and B. Bodner-Adler Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis Am J Obstet Gynecol 188 2003 752 758
72. J.C. Hauth, R.L. Goldenberg, and W.W. Andrews Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis N Engl J Med 333 1995 1732 1736
73. H.M. McDonald, J.A. O'Loughlin, and R. Vigneswaran Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial Br J Obstet Gynaecol 104 1997 1391 1397
74. W.J. Morales, S. Schorr, and J. Albritton Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study Am J Obstet Gynecol 171 1994 345 347
75. P. Brocklehurst, M. Hannah, and H. McDonald Interventions for treating bacterial vaginosis in pregnancy Cochrane Database Syst Rev 2 2000 CD000262
76. J.C. Carey, M.A. Klebanoff, and J.C. Hauth Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units N Engl J Med 342 2000 534 540
77. S. Cauci, P. Thorsen, and D.E. Schendel Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes J Clin Microbiol 41 2003 435 438
78. S. Cauci, J. McGregor, and P. Thorsen Combination of vaginal pH with vaginal sialidase and prolidase activities for prediction of low birth weight and preterm birth Am J Obstet Gynecol 192 2005 489 496
79. G.A. Macones, S. Parry, and M. Elkousy A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth Am J Obstet Gynecol 190 2004 1504 1508
80. A.P. Korn, G. Bolan, and N. Padian Plasma cell endometritis in women with symptomatic bacterial vaginosis Obstet Gynecol 85 1995 387 390
81. J. Paavonen, K. Teisala, and P.K. Heinonen Microbiological and histopathological findings in acute pelvic inflammatory disease Br J Obstet Gynaecol 94 1987 454 460
82. J.F. Peipert, R.B. Ness, and J. Blume Pelvic Inflammatory Disease Evaluation and Clinical Health Study Investigators. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease Am J Obstet Gynecol 184 2001 856 863
83. D.A. Eschenbach, S. Hillier, and C. Critchlow Diagnosis and clinical manifestations of bacterial vaginosis Am J Obstet Gynecol 158 1988 819 828
84. S.L. Hillier, N.B. Kiviat, and S.E. Hawes Role of bacterial vaginosis-associated microorganisms in endometritis Am J Obstet Gynecol 175 1996 435 441
85. H.C. Wiesenfeld, S.L. Hillier, and M.A. Krohn Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease Obstet Gynecol 100 2002 456 463
86. J.D. Wilson, S.G. Ralph, and A.J. Rutherford Rates of bacterial vaginosis in women undergoing in vitro fertilisation for different types of infertility BJOG 109 2002 714 717
87. J. Paavonen, P.L. Roberts, and C.E. Stevens Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin Am J Obstet Gynecol 161 1989 128 135
88. J.R. Schwebke, M.B. Schulien, and M. Zajackowski Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis Infect Dis Obstet Gynecol 3 1995 119 122
89. J.R. Schwebke, and H.L. Weiss Interrelationships of bacterial vaginosis and cervical inflammation Sex Transm Dis 29 2002 59 64
90. H.L. Martin, B.A. Richardson, and P.M. Nyange Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition J Infect Dis 180 1999 1863 1868
91. M.I. Alvarez-Olmos, M.M. Barousse, and L. Rajan Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis Sex Transm Dis 31 2004 393 400
92. C.R. Cohen, A. Duerr, and N. Pruithithada Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand AIDS 9 1995 1093 1097
93. N. Sewankambo, R.H. Gray, and M.J. Wawer HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis Lancet 350 1997 546 550
94. F.B. Hashemi, M. Ghassemi, and S. Faro Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis J Infect Dis 181 2000 1574 1580
95. A.N. Chaudry, P.J. Travers, and J. Yuenger Analysis of vaginal acetic acid in patients undergoing treatment for bacterial vaginosis J Clin Microbiol 42 2004 5170 5175
96. L. Myziuk, B. Romanowski, and S.C. Johnson BVBlue test for diagnosis of bacterial vaginosis J Clin Microbiol 41 2003 1925 1928
97. P.E. Hay Therapy of bacterial vaginosis J Antimicrob Chemother 41 1998 6 9
98. K.Y. Kane, and R. Pierce Clinical inquiries. What are the most effective treatments for bacterial vaginosis in nonpregnant women? J Fam Pract 50 2001 399 400
99. R.H. Beigi, M.N. Austin, and L.A. Meyn Antimicrobial resistance associated with the treatment of bacterial vaginosis Am J Obstet Gynecol 191 2004 1124 1129
100. F.A. Baylson, P. Nyirjesy, and M.V. Weitz Treatment of recurrent bacterial vaginosis with tinidazole Obstet Gynecol 104 2004 931 932
101. Sobel JD, Schwebke J, Ferris D, et al. A clinical trial to evaluate efficacy of maintenance therapy with 0.75% metronidazole gel (MVG) to prevent recurrent bacterial vaginosis (BV). Presented at the World Vaginitis Conference. Costa Rica, January 10-13, 2004.